Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016;12(1):74-82.
doi: 10.1080/15504263.2016.1145778.

Patterns of Substance Use During Cognitive Enhancement Therapy: An 18-Month Randomized Feasibility Study

Shaun M Eack  1   2 , Susan S Hogarty  2 , Srihari S Bangalore  2 , Matcheri S Keshavan  3 , Jack R Cornelius  2
Affiliations
Randomized Controlled Trial

Patterns of Substance Use During Cognitive Enhancement Therapy: An 18-Month Randomized Feasibility Study

Shaun M Eack et al. J Dual Diagn. 2016.

Abstract

Objective: Substance use problems are common among people with schizophrenia, as are significant cognitive impairments. Because of potential shared neurobiological pathways, it is possible that cognitive remediation interventions may be associated with improvements in both substance use and cognition. This study examined the impact of cognitive remediation on alcohol and cannabis use and the cognitive correlates of changes in substance use among outpatients with schizophrenia.

Methods: Individuals with schizophrenia who were receiving outpatient services at a psychiatric clinic and had moderate or higher addiction severity scores (N = 31) were randomized to 18 months of cognitive enhancement therapy (n = 22) or usual care (n = 9). Cognitive enhancement therapy is a cognitive remediation approach that integrates computer-based training in attention, memory, and problem solving with a group-based social cognition curriculum. Usual care was provided to all participants and consisted of routine psychiatric care. Primary outcomes included days of alcohol and cannabis use, assessed with the Timeline Followback method every six months and modeled using penalized quasi-likelihood growth curves.

Results: Participants were on average 38.23 (SD = 13.44) years of age, had been ill for 14.19 (SD = 11.28) years, and were mostly male (n = 22, 71%), and about half were Caucasian (n = 16, 52%). Temporal patterns of substance use days were highly variable and followed nonlinear trajectories. Intent-to-treat analyses indicated that, compared to patients only receiving usual care, those receiving cognitive enhancement therapy were significantly less likely to use alcohol (OR = .22; 95% CI: .05, .90; p = .036), but not cannabis (OR = 1.89; 95% CI: .02, 142.99; p = .774) over time, and they reduced their alcohol use at significantly accelerated rates (OR = 1.02; 95% CI: 1.01, 1.03; p = .003). Changes in cognition were variably associated with substance use outcomes, although improvements in visual learning and reasoning and problem solving were both consistently related to reduced alcohol and cannabis use.

Conclusions: Cognitive remediation may be effective for improving some substance use problems in schizophrenia. Visual learning and problem-solving deficits may be particularly important targets of such interventions, given their association with reduced alcohol and cannabis use. This study is registered at clinicaltrials.gov under #NCT01292577.

Keywords: Cognitive remediation; schizophrenia; substance use disorder.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patterns of Substance Use During an 18-Month Trial of Cognitive Enhancement Therapy or Treatment as Usual for Substance Misusing Schizophrenia.
See this image and copyright information in PMC

References

    1. Bahorik AL, Newhill CE, Eack SM. Neurocognitive functioning of individuals with schizophrenia using and not using drugs. Schizophrenia Bulletin. 2014;40(4):856–867. doi: 10.1093/schbul/sbt099. - DOI - PMC - PubMed
    1. Barrowclough C, Haddock G, Wykes T, Beardmore R, Conrod P, Craig T, Tarrier N. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: Randomised controlled trial. BMJ. 2010;341:c6325. doi: 10.1136/bmj.c6325. - DOI - PMC - PubMed
    1. Bates ME, Buckman JF, Nguyen TT. A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders. Neuropsychology Review. 2013;23(1):27–47. doi: 10.1007/s11065-013-9228-3. - DOI - PMC - PubMed
    1. Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry. 2006;63(4):426–432. doi: 10.1001/archpsyc.63.4.426. - DOI - PubMed
    1. Ben-Yishay Y, Piasetsky EB, Rattok J. A systematic method for ameliorating disorders in basic attention. In: Meir MJ, Benton AL, Diller L, editors. Neuropsychological rehabilitation. Guilford Press; New York: 1985. pp. 165–181.

Publication types

MeSH terms

Associated data